Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
69.41
-1.37 (-1.94%)
At close: Mar 6, 2026, 4:00 PM EST
68.69
-0.72 (-1.04%)
After-hours: Mar 6, 2026, 7:42 PM EST
Solventum Revenue
In the year 2025, Solventum had annual revenue of $8.33B with 0.86% growth. Solventum had revenue of $2.00B in the quarter ending December 31, 2025, a decrease of -3.71%.
Revenue (ttm)
$8.33B
Revenue Growth
+0.86%
P/S Ratio
1.45
Revenue / Employee
$378,409
Employees
22,000
Market Cap
12.04B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.24B |
| Avantor | 6.55B |
| Bausch + Lomb | 5.10B |
| Hologic | 4.13B |
| The Cooper Companies | 4.09B |
| Align Technology | 4.03B |
| AptarGroup | 3.78B |
| West Pharmaceutical Services | 3.07B |
SOLV News
- 5 days ago - Solventum: Improvements Come Slow - Seeking Alpha
- 9 days ago - Solventum Corporation (SOLV) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Solventum beats quarterly estimates on strong demand for surgical products - Reuters
- 9 days ago - Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance - PRNewsWire
- 4 weeks ago - Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026 - PRNewsWire
- 2 months ago - Solventum Completes Acquisition of Acera Surgical - PRNewsWire
- 2 months ago - Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy - PRNewsWire
- 2 months ago - Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength - PRNewsWire